WEBULL
News
BSX-PRA
122.18
0.00%
0.00
BUZZ-Medtech: Clear split between gainers and losers in 2025
Reuters · 12/31/2025 12:45
Acotec Scientific Holdings Ltd. Held Extraordinary General Meeting
Reuters · 12/31/2025 07:45
BOSTON SCIENTIFIC CORP <BSX.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $120 FROM $130
Reuters · 12/18/2025 12:55
U.S. RESEARCH ROUNDUP-Autozone, Coursera, Lennar
Reuters · 12/18/2025 06:42
U.S. RESEARCH ROUNDUP-Airbnb, Garrett Motion, Range Resources
Reuters · 12/17/2025 07:13
BOSTON SCIENTIFIC CORP <BSX.N>: RBC RAISES TARGET PRICE TO $130 FROM $125
Reuters · 12/17/2025 04:27
Acotec Scientific Holdings Ltd. Announces Date for Extraordinary General Meeting
Reuters · 12/16/2025 22:15
Proxy Proposal on Continuing Connected Transactions to Be Voted at Acotec Scientific Holdings Ltd. Extraordinary General Meeting
Reuters · 12/16/2025 22:10
Boston Scientific Files Initial Beneficial Ownership Statement for EVP, Global Operations Padraig Andrew O'Connor
Reuters · 12/08/2025 21:50
Acotec Scientific Gains PRC Approval for Microcatheter V-Otter
Reuters · 12/03/2025 08:42
Boston Scientific Approves 2026 Executive Bonus and Performance Share Plans
Reuters · 11/19/2025 21:21
Acotec Scientific Wins PRC Approval for Coronary Over-the-Wire Balloon Catheter
Reuters · 11/18/2025 09:55
Elutia Q3 revenue falls short of estimates, gross margin improves
Reuters · 11/06/2025 22:32
Boston Scientific Director Ellen M. Zane Reports Sale of Common Shares
Reuters · 11/06/2025 21:41
Elutia Inc. reports Q3 net sales of $3.3 million
Reuters · 11/06/2025 21:26
EVP & Group President Cardiology Joseph Michael Fitzgerald Reports Disposal of Boston Scientific Corporation Common Shares
Reuters · 11/04/2025 21:17
Boston Scientific Executives to Join Wolfe Research Healthcare Conference
Reuters · 11/03/2025 13:02
BOSTON SCIENTIFIC ANNOUNCES UPCOMING INVESTOR CONFERENCE SCHEDULE
Reuters · 11/03/2025 13:00
Boston Scientific posts Q3 net income of $755 million
Reuters · 11/03/2025 11:32
Boston Scientific Director Ellen M. Zane Reports Sale of Common Shares
Reuters · 10/28/2025 21:45
More
Webull provides a variety of real-time BSX-PRA stock news. You can receive the latest news about Boston Scientific Corporation through multiple platforms. This information may help you make smarter investment decisions.
About BSX-PRA
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions. Its Urology and Neuromodulation business develops and manufactures devices to treat various urological, neurological movement disorders and pelvic conditions. Its Cardiac Rhythm Management develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment include Interventional Cardiology and Peripheral Interventions. Its Interventional Cardiology develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Its product offerings include 360 Clips and RESONATE, among others.